Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

September 01, 2004; Volume 310,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Andersson, Carl Magnus

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  2. Arias, Esperanza

    1. You have access
      ITH4012 (Ethyl 5-Amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a Novel Acetylcholinesterase Inhibitor with “Calcium Promotor” and Neuroprotective Properties
      Camilo Orozco, Cristobal de los Rios, Esperanza Arias, Rafael León, Antonio G. García, Jose L. Marco, Mercedes Villarroya and Manuela G. López
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 987-994; DOI: https://doi.org/10.1124/jpet.104.068189
  3. Arnone, Michèle

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  4. Aubin, N.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782

B

  1. Baer, Philip G.

    1. You have access
      Regional Hemodynamic Effects of the N-(2-Benzoylphenyl)-l-tyrosine Peroxisome Proliferator-Activated Receptor-γ Ligand, GI 262570 [(S)-2-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic Acid], in Conscious Rats
      Sheila M Gardiner, Derek J. R. Nunez, Philip G. Baer, Kathleen K. Brown and Terence Bennett
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1226-1233; DOI: https://doi.org/10.1124/jpet.104.068817
  2. Balázsa, Tamás

    1. You have access
      P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices
      Lilla Papp, Tamás Balázsa, Attila Köfalvi, Ferenc Erdélyi, Gábor Szabó, E. Sylvester Vizi and Beáta Sperlágh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 973-980; DOI: https://doi.org/10.1124/jpet.104.066712
  3. Banfi, Cristina

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  4. Barcella, Simona

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  5. Barneoud, P.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  6. Barth, Francis

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  7. Bennett, Terence

    1. You have access
      Regional Hemodynamic Effects of the N-(2-Benzoylphenyl)-l-tyrosine Peroxisome Proliferator-Activated Receptor-γ Ligand, GI 262570 [(S)-2-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic Acid], in Conscious Rats
      Sheila M Gardiner, Derek J. R. Nunez, Philip G. Baer, Kathleen K. Brown and Terence Bennett
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1226-1233; DOI: https://doi.org/10.1124/jpet.104.068817
  8. Benowitz, Neal L.

    1. You have access
      Mentholated Cigarette Smoking Inhibits Nicotine Metabolism
      Neal L. Benowitz, Brenda Herrera and Peyton Jacob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1208-1215; DOI: https://doi.org/10.1124/jpet.104.066902
  9. Bettler, Bernhard

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  10. Blair, Robert E.

    1. You have access
      Epileptogenesis Causes Acute and Chronic Increases in GABAA Receptor Endocytosis That Contributes to the Induction and Maintenance of Seizures in the Hippocampal Culture Model of Acquired Epilepsy
      Robert E. Blair, Sompong Sombati, David C. Lawrence, Brendan D. McCay and Robert J. DeLorenzo
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 871-880; DOI: https://doi.org/10.1124/jpet.104.068478
  11. Bradbury, J. Alyce

    1. You have access
      CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products
      Tracy C. DeLozier, Cheng-Chung Tsao, Sherry J. Coulter, Julie Foley, J. Alyce Bradbury, Darryl C. Zeldin and Joyce A. Goldstein
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 845-854; DOI: https://doi.org/10.1124/jpet.104.067819
  12. Bradley, Stefania Risso

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  13. Brann, Mark R.

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  14. Brausch, Isolde

    1. You have access
      Flavonoids from Artichoke (Cynara scolymus L.) Up-Regulate Endothelial-Type Nitric-Oxide Synthase Gene Expression in Human Endothelial Cells
      Huige Li, Ning Xia, Isolde Brausch, Ying Yao and Ulrich Förstermann
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 926-932; DOI: https://doi.org/10.1124/jpet.104.066639
  15. Brimijoin, Stephen

    1. You have access
      An Engineered Cocaine Hydrolase Blunts and Reverses Cardiovascular Responses to Cocaine in Rats
      Yang Gao and Stephen Brimijoin
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1046-1052; DOI: https://doi.org/10.1124/jpet.104.068122
  16. Brown, Kathleen K.

    1. You have access
      Regional Hemodynamic Effects of the N-(2-Benzoylphenyl)-l-tyrosine Peroxisome Proliferator-Activated Receptor-γ Ligand, GI 262570 [(S)-2-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic Acid], in Conscious Rats
      Sheila M Gardiner, Derek J. R. Nunez, Philip G. Baer, Kathleen K. Brown and Terence Bennett
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1226-1233; DOI: https://doi.org/10.1124/jpet.104.068817
  17. Bubar, Marcy J.

    1. You have access
      Contribution of Serotonin (5-Hydroxytryptamine; 5-HT) 5-HT2 Receptor Subtypes to the Hyperlocomotor Effects of Cocaine: Acute and Chronic Pharmacological Analyses
      Malgorzata Filip, Marcy J. Bubar and Kathryn A. Cunningham
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1246-1254; DOI: https://doi.org/10.1124/jpet.104.068841
  18. Bui, Tot

    1. You have access
      Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein
      Erica L. Woodahl, Ziping Yang, Tot Bui, Danny D. Shen and Rodney J. Y. Ho
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1199-1207; DOI: https://doi.org/10.1124/jpet.104.065383
  19. Buikema, Hendrik

    1. You have access
      Low Sodium Modifies the Vascular Effects of Angiotensin-Converting Enzyme Inhibitor Therapy in Healthy Rats
      Menno J. A. Kocks, Simone Gschwend, Dick de Zeeuw, Gerjan Navis and Hendrik Buikema
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1183-1189; DOI: https://doi.org/10.1124/jpet.104.067272
  20. Bumpus, Namandjé N.

    1. You have access
      Metabolism of N,N′,N″-Triethylenethiophosphoramide by CYP2B1 and CYP2B6 Results in the Inactivation of Both Isoforms by Two Distinct Mechanisms
      Erin Harleton, Marie Webster, Namandjé N. Bumpus, Ute M. Kent, James M. Rae and Paul F. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1011-1019; DOI: https://doi.org/10.1124/jpet.104.069112
  21. Burcham, Philip C.

    1. You have access
      Strong Protein Adduct Trapping Accompanies Abolition of Acrolein-Mediated Hepatotoxicity by Hydralazine in Mice
      Lisa M. Kaminskas, Simon M. Pyke and Philip C. Burcham
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1003-1010; DOI: https://doi.org/10.1124/jpet.104.067330
  22. Burnier, P.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782

C

  1. Cagetti, Elisabetta

    1. You have access
      Altered Pharmacology of Synaptic and Extrasynaptic GABAA Receptors on CA1 Hippocampal Neurons Is Consistent with Subunit Changes in a Model of Alcohol Withdrawal and Dependence
      Jing Liang, Elisabetta Cagetti, Richard W. Olsen and Igor Spigelman
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1234-1245; DOI: https://doi.org/10.1124/jpet.104.067983
  2. Caille, D.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  3. Campiani, Giuseppe

    1. You have access
      Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XL
      Margaret M. Mc Gee, Lisa M. Greene, Susan Ledwidge, Giuseppe Campiani, Vito Nacci, Mark Lawler, D. Clive Williams and Daniela M. Zisterer
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1084-1095; DOI: https://doi.org/10.1124/jpet.104.067561
  4. Carter, C.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  5. Challiss, R. A. John

    1. You have access
      Functional Selectivity of Muscarinic Receptor Antagonists for Inhibition of M3-Mediated Phosphoinositide Responses in Guinea Pig Urinary Bladder and Submandibular Salivary Gland
      Carl P. Nelson, Paul Gupta, Carolyn M. Napier, Stefan R. Nahorski and R. A. John Challiss
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1255-1265; DOI: https://doi.org/10.1124/jpet.104.067140
  6. Chaperon, Frederique

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  7. Charieras, T.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  8. Chaudary, Naz

    1. You have access
      The Adenosine Transporter, mENT1, Is a Target for Adenosine Receptor Signaling and Protein Kinase Cϵ in Hypoxic and Pharmacological Preconditioning in the Mouse Cardiomyocyte Cell Line, HL-1
      Naz Chaudary, Zlatina Naydenova, Irina Shuralyova and Imogen R. Coe
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1190-1198; DOI: https://doi.org/10.1124/jpet.104.067157
  9. Chen, Feng

    1. You have access
      Chronic Antidepressant Treatment Causes a Selective Reduction of μ-Opioid Receptor Binding and Functional Coupling to G Proteins in the Amygdala of Fawn-Hooded Rats
      Feng Chen and Andrew J. Lawrence
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1020-1026; DOI: https://doi.org/10.1124/jpet.104.068692
  10. Chen, Jun

    1. You have access
      Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates
      Xiaobin Jia, Jun Chen, Huimin Lin and Ming Hu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1103-1113; DOI: https://doi.org/10.1124/jpet.104.068403
  11. Cirino, Giuseppe

    1. You have access
      Enhanced Anti-Inflammatory Potency of a Nitric Oxide-Releasing Derivative of Flunisolide: Role of Nuclear Factor-κB
      John L. Wallace, Gianni Rizzo, Giuseppe Cirino, Piero Del Soldato and Stefano Fiorucci
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1096-1102; DOI: https://doi.org/10.1124/jpet.104.067850
  12. Coe, Imogen R.

    1. You have access
      The Adenosine Transporter, mENT1, Is a Target for Adenosine Receptor Signaling and Protein Kinase Cϵ in Hypoxic and Pharmacological Preconditioning in the Mouse Cardiomyocyte Cell Line, HL-1
      Naz Chaudary, Zlatina Naydenova, Irina Shuralyova and Imogen R. Coe
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1190-1198; DOI: https://doi.org/10.1124/jpet.104.067157
  13. Coffey, G. P.

    1. You have access
      In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells
      G. P. Coffey, E. Stefanich, S. Palmieri, R. Eckert, J. Padilla-Eagar, P. J. Fielder and S. Pippig
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 896-904; DOI: https://doi.org/10.1124/jpet.104.067611
  14. Congy, Christian

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  15. Coulter, Sherry J.

    1. You have access
      CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products
      Tracy C. DeLozier, Cheng-Chung Tsao, Sherry J. Coulter, Julie Foley, J. Alyce Bradbury, Darryl C. Zeldin and Joyce A. Goldstein
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 845-854; DOI: https://doi.org/10.1124/jpet.104.067819
  16. Coy, David H.

    1. You have access
      Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3
      Samuel A. Mantey, David H. Coy, Laurence K. Entsuah and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1161-1170; DOI: https://doi.org/10.1124/jpet.104.066761
  17. Croke, David T.

    1. You have access
      Ethologically Based Resolution of D2-Like Dopamine Receptor Agonist-versus Antagonist-Induced Behavioral Topography in Dopamine- and Adenosine 3′,5′-Monophosphate-Regulated Phosphoprotein of 32 kDa “Knockout” Mutants Congenic on the C57BL/6 Genetic Background
      Rachel E. Nally, Anthony Kinsella, Orna Tighe, David T. Croke, Allen A. Fienberg, Paul Greengard and John L. Waddington
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1281-1287; DOI: https://doi.org/10.1124/jpet.104.068957
  18. Crooks, Peter A.

    1. You have access
      Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters
      Dennis K. Miller, Peter A. Crooks, Guangrong Zheng, Vladimir P. Grinevich, Seth D. Norrholm and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1035-1045; DOI: https://doi.org/10.1124/jpet.104.068098
  19. Cryan, John F.

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  20. Cunningham, Kathryn A.

    1. You have access
      Contribution of Serotonin (5-Hydroxytryptamine; 5-HT) 5-HT2 Receptor Subtypes to the Hyperlocomotor Effects of Cocaine: Acute and Chronic Pharmacological Analyses
      Malgorzata Filip, Marcy J. Bubar and Kathryn A. Cunningham
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1246-1254; DOI: https://doi.org/10.1124/jpet.104.068841
  21. Curet, O.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782

D

  1. D'Amico, Michele

    1. You have access
      The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1
      Clara Di Filippo, Francesco Rossi, Ennio Ongini, Piero Del Soldato, Mauro Perretti and Michele D'Amico
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1133-1141; DOI: https://doi.org/10.1124/jpet.104.068726
  2. D'Orio, Vincent

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  3. Davis, Robert E.

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  4. DeLorenzo, Robert J.

    1. You have access
      Epileptogenesis Causes Acute and Chronic Increases in GABAA Receptor Endocytosis That Contributes to the Induction and Maintenance of Seizures in the Hippocampal Culture Model of Acquired Epilepsy
      Robert E. Blair, Sompong Sombati, David C. Lawrence, Brendan D. McCay and Robert J. DeLorenzo
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 871-880; DOI: https://doi.org/10.1124/jpet.104.068478
  5. de los Rios, Cristobal

    1. You have access
      ITH4012 (Ethyl 5-Amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a Novel Acetylcholinesterase Inhibitor with “Calcium Promotor” and Neuroprotective Properties
      Camilo Orozco, Cristobal de los Rios, Esperanza Arias, Rafael León, Antonio G. García, Jose L. Marco, Mercedes Villarroya and Manuela G. López
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 987-994; DOI: https://doi.org/10.1124/jpet.104.068189
  6. DeLozier, Tracy C.

    1. You have access
      CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products
      Tracy C. DeLozier, Cheng-Chung Tsao, Sherry J. Coulter, Julie Foley, J. Alyce Bradbury, Darryl C. Zeldin and Joyce A. Goldstein
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 845-854; DOI: https://doi.org/10.1124/jpet.104.067819
  7. Del Soldato, Piero

    1. You have access
      Enhanced Anti-Inflammatory Potency of a Nitric Oxide-Releasing Derivative of Flunisolide: Role of Nuclear Factor-κB
      John L. Wallace, Gianni Rizzo, Giuseppe Cirino, Piero Del Soldato and Stefano Fiorucci
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1096-1102; DOI: https://doi.org/10.1124/jpet.104.067850
    2. You have access
      The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1
      Clara Di Filippo, Francesco Rossi, Ennio Ongini, Piero Del Soldato, Mauro Perretti and Michele D'Amico
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1133-1141; DOI: https://doi.org/10.1124/jpet.104.068726
  8. De Simoni, Grazia

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  9. Desta, Zeruesenay

    1. You have access
      Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6
      Zeruesenay Desta, Bryan A. Ward, Nadia V. Soukhova and David A. Flockhart
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1062-1075; DOI: https://doi.org/10.1124/jpet.104.065607
  10. de Zeeuw, Dick

    1. You have access
      Low Sodium Modifies the Vascular Effects of Angiotensin-Converting Enzyme Inhibitor Therapy in Healthy Rats
      Menno J. A. Kocks, Simone Gschwend, Dick de Zeeuw, Gerjan Navis and Hendrik Buikema
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1183-1189; DOI: https://doi.org/10.1124/jpet.104.067272
  11. Di Filippo, Clara

    1. You have access
      The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1
      Clara Di Filippo, Francesco Rossi, Ennio Ongini, Piero Del Soldato, Mauro Perretti and Michele D'Amico
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1133-1141; DOI: https://doi.org/10.1124/jpet.104.068726
  12. Dogné, Jean-Michel

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  13. Dolber, Paul C.

    1. You have access
      Inhibition of Bladder Activity by 5-Hydroxytryptamine1 Serotonin Receptor Agonists in Cats with Chronic Spinal Cord Injury
      Baojun Gu, Kenneth J. Olejar, Jerome P. Reiter, Karl B. Thor and Paul C. Dolber
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1266-1272; DOI: https://doi.org/10.1124/jpet.103.063842
  14. Dunlop, John

    1. You have access
      Ligand Dependency of 5-Hydroxytryptamine 2C Receptor Internalization
      Brian D. Schlag, Zhuangwei Lou, Myles Fennell and John Dunlop
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 865-870; DOI: https://doi.org/10.1124/jpet.104.067306
  15. Dwoskin, Linda P.

    1. You have access
      Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters
      Dennis K. Miller, Peter A. Crooks, Guangrong Zheng, Vladimir P. Grinevich, Seth D. Norrholm and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1035-1045; DOI: https://doi.org/10.1124/jpet.104.068098

E

  1. Eckert, R.

    1. You have access
      In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells
      G. P. Coffey, E. Stefanich, S. Palmieri, R. Eckert, J. Padilla-Eagar, P. J. Fielder and S. Pippig
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 896-904; DOI: https://doi.org/10.1124/jpet.104.067611
  2. Entsuah, Laurence K.

    1. You have access
      Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3
      Samuel A. Mantey, David H. Coy, Laurence K. Entsuah and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1161-1170; DOI: https://doi.org/10.1124/jpet.104.066761
  3. Erdélyi, Ferenc

    1. You have access
      P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices
      Lilla Papp, Tamás Balázsa, Attila Köfalvi, Ferenc Erdélyi, Gábor Szabó, E. Sylvester Vizi and Beáta Sperlágh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 973-980; DOI: https://doi.org/10.1124/jpet.104.066712
  4. Erickson, Kelly

    1. You have access
      Botulinum Toxin Type A Targets RhoB to Inhibit Lysophosphatidic Acid-Stimulated Actin Reorganization and Acetylcholine Release in Nerve Growth Factor-Treated PC12 Cells
      Hiroshi Ishida, Xieping Zhang, Kelly Erickson and Prabhati Ray
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 881-889; DOI: https://doi.org/10.1124/jpet.104.065318
  5. Eshleman, Amy J.

    1. You have access
      Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System
      Clare J. Wilhelm, Robert A. Johnson, Paul G. Lysko, Amy J. Eshleman and Aaron Janowsky
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1142-1151; DOI: https://doi.org/10.1124/jpet.104.067314

F

  1. Fabis, Marzena J.

    1. You have access
      The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation
      Gwen S. Scott, Rhonda B. Kean, Tatiana Mikheeva, Marzena J. Fabis, Jon G. Mabley, Csaba Szabó and D. Craig Hooper
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1053-1061; DOI: https://doi.org/10.1124/jpet.103.063214
  2. Fennell, Myles

    1. You have access
      Ligand Dependency of 5-Hydroxytryptamine 2C Receptor Internalization
      Brian D. Schlag, Zhuangwei Lou, Myles Fennell and John Dunlop
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 865-870; DOI: https://doi.org/10.1124/jpet.104.067306
  3. Fielder, P. J.

    1. You have access
      In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells
      G. P. Coffey, E. Stefanich, S. Palmieri, R. Eckert, J. Padilla-Eagar, P. J. Fielder and S. Pippig
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 896-904; DOI: https://doi.org/10.1124/jpet.104.067611
  4. Fienberg, Allen A.

    1. You have access
      Ethologically Based Resolution of D2-Like Dopamine Receptor Agonist-versus Antagonist-Induced Behavioral Topography in Dopamine- and Adenosine 3′,5′-Monophosphate-Regulated Phosphoprotein of 32 kDa “Knockout” Mutants Congenic on the C57BL/6 Genetic Background
      Rachel E. Nally, Anthony Kinsella, Orna Tighe, David T. Croke, Allen A. Fienberg, Paul Greengard and John L. Waddington
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1281-1287; DOI: https://doi.org/10.1124/jpet.104.068957
  5. Filip, Malgorzata

    1. You have access
      Contribution of Serotonin (5-Hydroxytryptamine; 5-HT) 5-HT2 Receptor Subtypes to the Hyperlocomotor Effects of Cocaine: Acute and Chronic Pharmacological Analyses
      Malgorzata Filip, Marcy J. Bubar and Kathryn A. Cunningham
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1246-1254; DOI: https://doi.org/10.1124/jpet.104.068841
  6. Finance, Olivier

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  7. Fiorucci, Stefano

    1. You have access
      Enhanced Anti-Inflammatory Potency of a Nitric Oxide-Releasing Derivative of Flunisolide: Role of Nuclear Factor-κB
      John L. Wallace, Gianni Rizzo, Giuseppe Cirino, Piero Del Soldato and Stefano Fiorucci
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1096-1102; DOI: https://doi.org/10.1124/jpet.104.067850
  8. Flockhart, David A.

    1. You have access
      Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6
      Zeruesenay Desta, Bryan A. Ward, Nadia V. Soukhova and David A. Flockhart
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1062-1075; DOI: https://doi.org/10.1124/jpet.104.065607
  9. Foley, Julie

    1. You have access
      CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products
      Tracy C. DeLozier, Cheng-Chung Tsao, Sherry J. Coulter, Julie Foley, J. Alyce Bradbury, Darryl C. Zeldin and Joyce A. Goldstein
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 845-854; DOI: https://doi.org/10.1124/jpet.104.067819
  10. Forkert, Poh-Gek

    1. You have access
      Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung
      Andrea C. Simmonds, Burhan I. Ghanayem, Ashish Sharma, Christopher A. Reilly, Brandie Millen, Garold S. Yost and Poh-Gek Forkert
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 855-864; DOI: https://doi.org/10.1124/jpet.104.068171
  11. Förstermann, Ulrich

    1. You have access
      Flavonoids from Artichoke (Cynara scolymus L.) Up-Regulate Endothelial-Type Nitric-Oxide Synthase Gene Expression in Human Endothelial Cells
      Huige Li, Ning Xia, Isolde Brausch, Ying Yao and Ulrich Förstermann
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 926-932; DOI: https://doi.org/10.1124/jpet.104.066639
  12. Froestl, Wolfgang

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  13. Fujiwara, Hironori

    1. You have access
      IC101 Induces Apoptosis by Akt Dephosphorylation via an Inhibition of Heat Shock Protein 90-ATP Binding Activity Accompanied by Preventing the Interaction with Akt in L1210 Cells
      Hironori Fujiwara, Tohru Yamakuni, Mitsuhiro Ueno, Masaaki Ishizuka, Takashi Shinkawa, Toshiaki Isobe and Yasushi Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1288-1295; DOI: https://doi.org/10.1124/jpet.104.065979

G

  1. Gao, Yang

    1. You have access
      An Engineered Cocaine Hydrolase Blunts and Reverses Cardiovascular Responses to Cocaine in Rats
      Yang Gao and Stephen Brimijoin
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1046-1052; DOI: https://doi.org/10.1124/jpet.104.068122
  2. García, Antonio G.

    1. You have access
      ITH4012 (Ethyl 5-Amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a Novel Acetylcholinesterase Inhibitor with “Calcium Promotor” and Neuroprotective Properties
      Camilo Orozco, Cristobal de los Rios, Esperanza Arias, Rafael León, Antonio G. García, Jose L. Marco, Mercedes Villarroya and Manuela G. López
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 987-994; DOI: https://doi.org/10.1124/jpet.104.068189
  3. Gardes, A.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  4. Gardiner, Sheila M

    1. You have access
      Regional Hemodynamic Effects of the N-(2-Benzoylphenyl)-l-tyrosine Peroxisome Proliferator-Activated Receptor-γ Ligand, GI 262570 [(S)-2-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic Acid], in Conscious Rats
      Sheila M Gardiner, Derek J. R. Nunez, Philip G. Baer, Kathleen K. Brown and Terence Bennett
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1226-1233; DOI: https://doi.org/10.1124/jpet.104.068817
  5. Gelosa, Paolo

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  6. Gentsch, Conrad

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  7. George, P.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  8. Ghanayem, Burhan I.

    1. You have access
      Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung
      Andrea C. Simmonds, Burhan I. Ghanayem, Ashish Sharma, Christopher A. Reilly, Brandie Millen, Garold S. Yost and Poh-Gek Forkert
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 855-864; DOI: https://doi.org/10.1124/jpet.104.068171
  9. Ghuysen, Alexandre

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  10. Gianazza, Elisabetta

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  11. Goldstein, Joyce A.

    1. You have access
      CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products
      Tracy C. DeLozier, Cheng-Chung Tsao, Sherry J. Coulter, Julie Foley, J. Alyce Bradbury, Darryl C. Zeldin and Joyce A. Goldstein
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 845-854; DOI: https://doi.org/10.1124/jpet.104.067819
  12. Grabovsky, Yury

    1. You have access
      Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles
      Yury Grabovsky and Ronald J. Tallarida
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 981-986; DOI: https://doi.org/10.1124/jpet.104.067264
  13. Greene, Lisa M.

    1. You have access
      Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XL
      Margaret M. Mc Gee, Lisa M. Greene, Susan Ledwidge, Giuseppe Campiani, Vito Nacci, Mark Lawler, D. Clive Williams and Daniela M. Zisterer
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1084-1095; DOI: https://doi.org/10.1124/jpet.104.067561
  14. Greengard, Paul

    1. You have access
      Ethologically Based Resolution of D2-Like Dopamine Receptor Agonist-versus Antagonist-Induced Behavioral Topography in Dopamine- and Adenosine 3′,5′-Monophosphate-Regulated Phosphoprotein of 32 kDa “Knockout” Mutants Congenic on the C57BL/6 Genetic Background
      Rachel E. Nally, Anthony Kinsella, Orna Tighe, David T. Croke, Allen A. Fienberg, Paul Greengard and John L. Waddington
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1281-1287; DOI: https://doi.org/10.1124/jpet.104.068957
  15. Grinevich, Vladimir P.

    1. You have access
      Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters
      Dennis K. Miller, Peter A. Crooks, Guangrong Zheng, Vladimir P. Grinevich, Seth D. Norrholm and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1035-1045; DOI: https://doi.org/10.1124/jpet.104.068098
  16. Gschwend, Simone

    1. You have access
      Low Sodium Modifies the Vascular Effects of Angiotensin-Converting Enzyme Inhibitor Therapy in Healthy Rats
      Menno J. A. Kocks, Simone Gschwend, Dick de Zeeuw, Gerjan Navis and Hendrik Buikema
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1183-1189; DOI: https://doi.org/10.1124/jpet.104.067272
  17. Gu, Baojun

    1. You have access
      Inhibition of Bladder Activity by 5-Hydroxytryptamine1 Serotonin Receptor Agonists in Cats with Chronic Spinal Cord Injury
      Baojun Gu, Kenneth J. Olejar, Jerome P. Reiter, Karl B. Thor and Paul C. Dolber
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1266-1272; DOI: https://doi.org/10.1124/jpet.103.063842
  18. Gubisne-Haberle, Diana

    1. You have access
      Protein Cross-Linkage Induced by Formaldehyde Derived from Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination of Methylamine
      Diana Gubisne-Haberle, Wayne Hill, Mychaylo Kazachkov, J. Steven Richardson and Peter H. Yu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1125-1132; DOI: https://doi.org/10.1124/jpet.104.068601
  19. Guerrini, Uliano

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  20. Gupta, Paul

    1. You have access
      Functional Selectivity of Muscarinic Receptor Antagonists for Inhibition of M3-Mediated Phosphoinositide Responses in Guinea Pig Urinary Bladder and Submandibular Salivary Gland
      Carl P. Nelson, Paul Gupta, Carolyn M. Napier, Stefan R. Nahorski and R. A. John Challiss
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1255-1265; DOI: https://doi.org/10.1124/jpet.104.067140

H

  1. Hacksell, Uli

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  2. Hanson, Julien

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  3. Harleton, Erin

    1. You have access
      Metabolism of N,N′,N″-Triethylenethiophosphoramide by CYP2B1 and CYP2B6 Results in the Inactivation of Both Isoforms by Two Distinct Mechanisms
      Erin Harleton, Marie Webster, Namandjé N. Bumpus, Ute M. Kent, James M. Rae and Paul F. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1011-1019; DOI: https://doi.org/10.1124/jpet.104.069112
  4. Harvey, Scott C.

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  5. Hattori, Kouji

    1. You have access
      A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
      Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki, Shigeru Matsuura, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1114-1124; DOI: https://doi.org/10.1124/jpet.104.068932
  6. Herrera, Brenda

    1. You have access
      Mentholated Cigarette Smoking Inhibits Nicotine Metabolism
      Neal L. Benowitz, Brenda Herrera and Peyton Jacob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1208-1215; DOI: https://doi.org/10.1124/jpet.104.066902
  7. Hill, Wayne

    1. You have access
      Protein Cross-Linkage Induced by Formaldehyde Derived from Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination of Methylamine
      Diana Gubisne-Haberle, Wayne Hill, Mychaylo Kazachkov, J. Steven Richardson and Peter H. Yu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1125-1132; DOI: https://doi.org/10.1124/jpet.104.068601
  8. Hiraizumi-Hiraoka, Yasuko

    1. You have access
      Identification of α-1L Adrenoceptor in Rabbit Ear Artery
      Yasuko Hiraizumi-Hiraoka, Takashi Tanaka, Hatsumi Yamamoto, Fumiko Suzuki and Ikunobu Muramatsu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 995-1002; DOI: https://doi.org/10.1124/jpet.104.066985
  9. Ho, Rodney J. Y.

    1. You have access
      Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein
      Erica L. Woodahl, Ziping Yang, Tot Bui, Danny D. Shen and Rodney J. Y. Ho
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1199-1207; DOI: https://doi.org/10.1124/jpet.104.065383
  10. Hollenberg, Paul F.

    1. You have access
      Metabolism of N,N′,N″-Triethylenethiophosphoramide by CYP2B1 and CYP2B6 Results in the Inactivation of Both Isoforms by Two Distinct Mechanisms
      Erin Harleton, Marie Webster, Namandjé N. Bumpus, Ute M. Kent, James M. Rae and Paul F. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1011-1019; DOI: https://doi.org/10.1124/jpet.104.069112
  11. Hooper, D. Craig

    1. You have access
      The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation
      Gwen S. Scott, Rhonda B. Kean, Tatiana Mikheeva, Marzena J. Fabis, Jon G. Mabley, Csaba Szabó and D. Craig Hooper
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1053-1061; DOI: https://doi.org/10.1124/jpet.103.063214
  12. Hu, Ming

    1. You have access
      Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates
      Xiaobin Jia, Jun Chen, Huimin Lin and Ming Hu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1103-1113; DOI: https://doi.org/10.1124/jpet.104.068403

I

  1. Ignatowski, Tracey A.

    1. You have access
      Brain-Derived Tumor Necrosis Factor-α and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant
      Jessica L. Reynolds, Tracey A. Ignatowski, Reeteka Sud and Robert N. Spengler
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1216-1225; DOI: https://doi.org/10.1124/jpet.104.067835
  2. Ikeda, Mizuho

    1. You have access
      Fenofibrate, Troglitazone, and 15-Deoxy-Δ12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion
      Kenju Shimomura, Hiroyuki Shimizu, Mizuho Ikeda, Shuichi Okada, Masafumi Kakei, Shigeji Matsumoto and Masatomo Mori
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1273-1280; DOI: https://doi.org/10.1124/jpet.104.067249
  3. Inoue, Koki

    1. You have access
      Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity
      Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676
  4. Ishida, Hiroshi

    1. You have access
      Botulinum Toxin Type A Targets RhoB to Inhibit Lysophosphatidic Acid-Stimulated Actin Reorganization and Acetylcholine Release in Nerve Growth Factor-Treated PC12 Cells
      Hiroshi Ishida, Xieping Zhang, Kelly Erickson and Prabhati Ray
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 881-889; DOI: https://doi.org/10.1124/jpet.104.065318
  5. Ishida, Junya

    1. You have access
      A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
      Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki, Shigeru Matsuura, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1114-1124; DOI: https://doi.org/10.1124/jpet.104.068932
  6. Ishizuka, Masaaki

    1. You have access
      IC101 Induces Apoptosis by Akt Dephosphorylation via an Inhibition of Heat Shock Protein 90-ATP Binding Activity Accompanied by Preventing the Interaction with Akt in L1210 Cells
      Hironori Fujiwara, Tohru Yamakuni, Mitsuhiro Ueno, Masaaki Ishizuka, Takashi Shinkawa, Toshiaki Isobe and Yasushi Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1288-1295; DOI: https://doi.org/10.1124/jpet.104.065979
  7. Isobe, Toshiaki

    1. You have access
      IC101 Induces Apoptosis by Akt Dephosphorylation via an Inhibition of Heat Shock Protein 90-ATP Binding Activity Accompanied by Preventing the Interaction with Akt in L1210 Cells
      Hironori Fujiwara, Tohru Yamakuni, Mitsuhiro Ueno, Masaaki Ishizuka, Takashi Shinkawa, Toshiaki Isobe and Yasushi Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1288-1295; DOI: https://doi.org/10.1124/jpet.104.065979
  8. Iwashita, Akinori

    1. You have access
      A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
      Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki, Shigeru Matsuura, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1114-1124; DOI: https://doi.org/10.1124/jpet.104.068932

J

  1. Jacob, Peyton

    1. You have access
      Mentholated Cigarette Smoking Inhibits Nicotine Metabolism
      Neal L. Benowitz, Brenda Herrera and Peyton Jacob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1208-1215; DOI: https://doi.org/10.1124/jpet.104.066902
  2. Janowsky, Aaron

    1. You have access
      Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System
      Clare J. Wilhelm, Robert A. Johnson, Paul G. Lysko, Amy J. Eshleman and Aaron Janowsky
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1142-1151; DOI: https://doi.org/10.1124/jpet.104.067314
  3. Jegham, S.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  4. Jensen, Robert T.

    1. You have access
      Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3
      Samuel A. Mantey, David H. Coy, Laurence K. Entsuah and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1161-1170; DOI: https://doi.org/10.1124/jpet.104.066761
  5. Jia, Xiaobin

    1. You have access
      Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates
      Xiaobin Jia, Jun Chen, Huimin Lin and Ming Hu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1103-1113; DOI: https://doi.org/10.1124/jpet.104.068403
  6. Johnson, Robert A.

    1. You have access
      Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System
      Clare J. Wilhelm, Robert A. Johnson, Paul G. Lysko, Amy J. Eshleman and Aaron Janowsky
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1142-1151; DOI: https://doi.org/10.1124/jpet.104.067314

K

  1. Kakei, Masafumi

    1. You have access
      Fenofibrate, Troglitazone, and 15-Deoxy-Δ12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion
      Kenju Shimomura, Hiroyuki Shimizu, Mizuho Ikeda, Shuichi Okada, Masafumi Kakei, Shigeji Matsumoto and Masatomo Mori
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1273-1280; DOI: https://doi.org/10.1124/jpet.104.067249
  2. Kaminskas, Lisa M.

    1. You have access
      Strong Protein Adduct Trapping Accompanies Abolition of Acrolein-Mediated Hepatotoxicity by Hydralazine in Mice
      Lisa M. Kaminskas, Simon M. Pyke and Philip C. Burcham
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1003-1010; DOI: https://doi.org/10.1124/jpet.104.067330
  3. Kaupmann, Klemens

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  4. Kazachkov, Mychaylo

    1. You have access
      Protein Cross-Linkage Induced by Formaldehyde Derived from Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination of Methylamine
      Diana Gubisne-Haberle, Wayne Hill, Mychaylo Kazachkov, J. Steven Richardson and Peter H. Yu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1125-1132; DOI: https://doi.org/10.1124/jpet.104.068601
  5. Kean, Rhonda B.

    1. You have access
      The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation
      Gwen S. Scott, Rhonda B. Kean, Tatiana Mikheeva, Marzena J. Fabis, Jon G. Mabley, Csaba Szabó and D. Craig Hooper
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1053-1061; DOI: https://doi.org/10.1124/jpet.103.063214
  6. Kelly, Peter H.

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  7. Kent, Ute M.

    1. You have access
      Metabolism of N,N′,N″-Triethylenethiophosphoramide by CYP2B1 and CYP2B6 Results in the Inactivation of Both Isoforms by Two Distinct Mechanisms
      Erin Harleton, Marie Webster, Namandjé N. Bumpus, Ute M. Kent, James M. Rae and Paul F. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1011-1019; DOI: https://doi.org/10.1124/jpet.104.069112
  8. Kinsella, Anthony

    1. You have access
      Ethologically Based Resolution of D2-Like Dopamine Receptor Agonist-versus Antagonist-Induced Behavioral Topography in Dopamine- and Adenosine 3′,5′-Monophosphate-Regulated Phosphoprotein of 32 kDa “Knockout” Mutants Congenic on the C57BL/6 Genetic Background
      Rachel E. Nally, Anthony Kinsella, Orna Tighe, David T. Croke, Allen A. Fienberg, Paul Greengard and John L. Waddington
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1281-1287; DOI: https://doi.org/10.1124/jpet.104.068957
  9. Kocks, Menno J. A.

    1. You have access
      Low Sodium Modifies the Vascular Effects of Angiotensin-Converting Enzyme Inhibitor Therapy in Healthy Rats
      Menno J. A. Kocks, Simone Gschwend, Dick de Zeeuw, Gerjan Navis and Hendrik Buikema
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1183-1189; DOI: https://doi.org/10.1124/jpet.104.067272
  10. Köfalvi, Attila

    1. You have access
      P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices
      Lilla Papp, Tamás Balázsa, Attila Köfalvi, Ferenc Erdélyi, Gábor Szabó, E. Sylvester Vizi and Beáta Sperlágh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 973-980; DOI: https://doi.org/10.1124/jpet.104.066712
  11. Kold, Henriette

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  12. Kolh, Philippe

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  13. Koob, George F.

    1. You have access
      Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity
      Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676
  14. Krishna, Murali C.

    1. You have access
      Novel Pharmacokinetic Measurement Using Electron Paramagnetic Resonance Spectroscopy and Simulation of in Vivo Decay of Various Nitroxyl Spin Probes in Mouse Blood
      Ken-ichiro Matsumoto, Murali C. Krishna and James B. Mitchell
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1076-1083; DOI: https://doi.org/10.1124/jpet.104.066647

L

  1. Lambermont, Bernard

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  2. Lawler, Mark

    1. You have access
      Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XL
      Margaret M. Mc Gee, Lisa M. Greene, Susan Ledwidge, Giuseppe Campiani, Vito Nacci, Mark Lawler, D. Clive Williams and Daniela M. Zisterer
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1084-1095; DOI: https://doi.org/10.1124/jpet.104.067561
  3. Lawrence, Andrew J.

    1. You have access
      Chronic Antidepressant Treatment Causes a Selective Reduction of μ-Opioid Receptor Binding and Functional Coupling to G Proteins in the Amygdala of Fawn-Hooded Rats
      Feng Chen and Andrew J. Lawrence
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1020-1026; DOI: https://doi.org/10.1124/jpet.104.068692
  4. Lawrence, David C.

    1. You have access
      Epileptogenesis Causes Acute and Chronic Increases in GABAA Receptor Endocytosis That Contributes to the Induction and Maintenance of Seizures in the Hippocampal Culture Model of Acquired Epilepsy
      Robert E. Blair, Sompong Sombati, David C. Lawrence, Brendan D. McCay and Robert J. DeLorenzo
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 871-880; DOI: https://doi.org/10.1124/jpet.104.068478
  5. Ledwidge, Susan

    1. You have access
      Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XL
      Margaret M. Mc Gee, Lisa M. Greene, Susan Ledwidge, Giuseppe Campiani, Vito Nacci, Mark Lawler, D. Clive Williams and Daniela M. Zisterer
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1084-1095; DOI: https://doi.org/10.1124/jpet.104.067561
  6. Le Fur, Gérard

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  7. Le Kim, A.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  8. León, Rafael

    1. You have access
      ITH4012 (Ethyl 5-Amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a Novel Acetylcholinesterase Inhibitor with “Calcium Promotor” and Neuroprotective Properties
      Camilo Orozco, Cristobal de los Rios, Esperanza Arias, Rafael León, Antonio G. García, Jose L. Marco, Mercedes Villarroya and Manuela G. López
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 987-994; DOI: https://doi.org/10.1124/jpet.104.068189
  9. Li, Huige

    1. You have access
      Flavonoids from Artichoke (Cynara scolymus L.) Up-Regulate Endothelial-Type Nitric-Oxide Synthase Gene Expression in Human Endothelial Cells
      Huige Li, Ning Xia, Isolde Brausch, Ying Yao and Ulrich Förstermann
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 926-932; DOI: https://doi.org/10.1124/jpet.104.066639
  10. Liang, Jing

    1. You have access
      Altered Pharmacology of Synaptic and Extrasynaptic GABAA Receptors on CA1 Hippocampal Neurons Is Consistent with Subunit Changes in a Model of Alcohol Withdrawal and Dependence
      Jing Liang, Elisabetta Cagetti, Richard W. Olsen and Igor Spigelman
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1234-1245; DOI: https://doi.org/10.1124/jpet.104.067983
  11. Lin, Huimin

    1. You have access
      Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates
      Xiaobin Jia, Jun Chen, Huimin Lin and Ming Hu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1103-1113; DOI: https://doi.org/10.1124/jpet.104.068403
  12. Lingenhoehl, Kurt

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  13. Lolivier, J.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  14. López, Manuela G.

    1. You have access
      ITH4012 (Ethyl 5-Amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a Novel Acetylcholinesterase Inhibitor with “Calcium Promotor” and Neuroprotective Properties
      Camilo Orozco, Cristobal de los Rios, Esperanza Arias, Rafael León, Antonio G. García, Jose L. Marco, Mercedes Villarroya and Manuela G. López
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 987-994; DOI: https://doi.org/10.1124/jpet.104.068189
  15. Lou, Zhuangwei

    1. You have access
      Ligand Dependency of 5-Hydroxytryptamine 2C Receptor Internalization
      Brian D. Schlag, Zhuangwei Lou, Myles Fennell and John Dunlop
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 865-870; DOI: https://doi.org/10.1124/jpet.104.067306
  16. Lupica, Carl R.

    1. You have access
      Differential Effects of Endogenous and Synthetic Cannabinoids on α7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
      Murat Oz, Li Zhang, Arippa Ravindran, Marisela Morales and Carl R. Lupica
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1152-1160; DOI: https://doi.org/10.1124/jpet.104.067751
  17. Lysko, Paul G.

    1. You have access
      Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System
      Clare J. Wilhelm, Robert A. Johnson, Paul G. Lysko, Amy J. Eshleman and Aaron Janowsky
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1142-1151; DOI: https://doi.org/10.1124/jpet.104.067314

M

  1. Mabley, Jon G.

    1. You have access
      The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation
      Gwen S. Scott, Rhonda B. Kean, Tatiana Mikheeva, Marzena J. Fabis, Jon G. Mabley, Csaba Szabó and D. Craig Hooper
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1053-1061; DOI: https://doi.org/10.1124/jpet.103.063214
  2. Magis, David

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  3. Makhay, Malath

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  4. Mantey, Samuel A.

    1. You have access
      Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3
      Samuel A. Mantey, David H. Coy, Laurence K. Entsuah and Robert T. Jensen
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1161-1170; DOI: https://doi.org/10.1124/jpet.104.066761
  5. Marc, C.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  6. Marco, Jose L.

    1. You have access
      ITH4012 (Ethyl 5-Amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a Novel Acetylcholinesterase Inhibitor with “Calcium Promotor” and Neuroprotective Properties
      Camilo Orozco, Cristobal de los Rios, Esperanza Arias, Rafael León, Antonio G. García, Jose L. Marco, Mercedes Villarroya and Manuela G. López
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 987-994; DOI: https://doi.org/10.1124/jpet.104.068189
  7. Marszalec, William

    1. You have access
      Mechanism of Action of Galantamine on N-Methyl-d-Aspartate Receptors in Rat Cortical Neurons
      Shigeki Moriguchi, William Marszalec, Xilong Zhao, Jay Z. Yeh and Toshio Narahashi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 933-942; DOI: https://doi.org/10.1124/jpet.104.067603
  8. Martinez, Serge

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  9. Maruani, Jeanne

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  10. Matsumoto, Ken-ichiro

    1. You have access
      Novel Pharmacokinetic Measurement Using Electron Paramagnetic Resonance Spectroscopy and Simulation of in Vivo Decay of Various Nitroxyl Spin Probes in Mouse Blood
      Ken-ichiro Matsumoto, Murali C. Krishna and James B. Mitchell
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1076-1083; DOI: https://doi.org/10.1124/jpet.104.066647
  11. Matsumoto, Shigeji

    1. You have access
      Fenofibrate, Troglitazone, and 15-Deoxy-Δ12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion
      Kenju Shimomura, Hiroyuki Shimizu, Mizuho Ikeda, Shuichi Okada, Masafumi Kakei, Shigeji Matsumoto and Masatomo Mori
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1273-1280; DOI: https://doi.org/10.1124/jpet.104.067249
  12. Matsuoka, Nobuya

    1. You have access
      A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
      Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki, Shigeru Matsuura, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1114-1124; DOI: https://doi.org/10.1124/jpet.104.068932
  13. Matsuura, Shigeru

    1. You have access
      A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
      Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki, Shigeru Matsuura, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1114-1124; DOI: https://doi.org/10.1124/jpet.104.068932
  14. McCay, Brendan D.

    1. You have access
      Epileptogenesis Causes Acute and Chronic Increases in GABAA Receptor Endocytosis That Contributes to the Induction and Maintenance of Seizures in the Hippocampal Culture Model of Acquired Epilepsy
      Robert E. Blair, Sompong Sombati, David C. Lawrence, Brendan D. McCay and Robert J. DeLorenzo
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 871-880; DOI: https://doi.org/10.1124/jpet.104.068478
  15. Mc Gee, Margaret M.

    1. You have access
      Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XL
      Margaret M. Mc Gee, Lisa M. Greene, Susan Ledwidge, Giuseppe Campiani, Vito Nacci, Mark Lawler, D. Clive Williams and Daniela M. Zisterer
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1084-1095; DOI: https://doi.org/10.1124/jpet.104.067561
  16. Mihara, Kayoko

    1. You have access
      A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
      Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki, Shigeru Matsuura, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1114-1124; DOI: https://doi.org/10.1124/jpet.104.068932
  17. Mikheeva, Tatiana

    1. You have access
      The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation
      Gwen S. Scott, Rhonda B. Kean, Tatiana Mikheeva, Marzena J. Fabis, Jon G. Mabley, Csaba Szabó and D. Craig Hooper
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1053-1061; DOI: https://doi.org/10.1124/jpet.103.063214
  18. Millen, Brandie

    1. You have access
      Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung
      Andrea C. Simmonds, Burhan I. Ghanayem, Ashish Sharma, Christopher A. Reilly, Brandie Millen, Garold S. Yost and Poh-Gek Forkert
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 855-864; DOI: https://doi.org/10.1124/jpet.104.068171
  19. Miller, Dennis K.

    1. You have access
      Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters
      Dennis K. Miller, Peter A. Crooks, Guangrong Zheng, Vladimir P. Grinevich, Seth D. Norrholm and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1035-1045; DOI: https://doi.org/10.1124/jpet.104.068098
  20. Mitchell, James B.

    1. You have access
      Novel Pharmacokinetic Measurement Using Electron Paramagnetic Resonance Spectroscopy and Simulation of in Vivo Decay of Various Nitroxyl Spin Probes in Mouse Blood
      Ken-ichiro Matsumoto, Murali C. Krishna and James B. Mitchell
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1076-1083; DOI: https://doi.org/10.1124/jpet.104.066647
  21. Mombereau, Cedric

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  22. Morales, Marisela

    1. You have access
      Differential Effects of Endogenous and Synthetic Cannabinoids on α7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
      Murat Oz, Li Zhang, Arippa Ravindran, Marisela Morales and Carl R. Lupica
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1152-1160; DOI: https://doi.org/10.1124/jpet.104.067751
  23. Mori, Masatomo

    1. You have access
      Fenofibrate, Troglitazone, and 15-Deoxy-Δ12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion
      Kenju Shimomura, Hiroyuki Shimizu, Mizuho Ikeda, Shuichi Okada, Masafumi Kakei, Shigeji Matsumoto and Masatomo Mori
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1273-1280; DOI: https://doi.org/10.1124/jpet.104.067249
  24. Moriguchi, Shigeki

    1. You have access
      Mechanism of Action of Galantamine on N-Methyl-d-Aspartate Receptors in Rat Cortical Neurons
      Shigeki Moriguchi, William Marszalec, Xilong Zhao, Jay Z. Yeh and Toshio Narahashi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 933-942; DOI: https://doi.org/10.1124/jpet.104.067603
  25. Morimont, Philippe

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  26. Muramatsu, Ikunobu

    1. You have access
      Identification of α-1L Adrenoceptor in Rabbit Ear Artery
      Yasuko Hiraizumi-Hiraoka, Takashi Tanaka, Hatsumi Yamamoto, Fumiko Suzuki and Ikunobu Muramatsu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 995-1002; DOI: https://doi.org/10.1124/jpet.104.066985
  27. Mussoni, Luciana

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  28. Mutoh, Seitaro

    1. You have access
      A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
      Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki, Shigeru Matsuura, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1114-1124; DOI: https://doi.org/10.1124/jpet.104.068932

N

  1. Nacci, Vito

    1. You have access
      Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XL
      Margaret M. Mc Gee, Lisa M. Greene, Susan Ledwidge, Giuseppe Campiani, Vito Nacci, Mark Lawler, D. Clive Williams and Daniela M. Zisterer
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1084-1095; DOI: https://doi.org/10.1124/jpet.104.067561
  2. Nahorski, Stefan R.

    1. You have access
      Functional Selectivity of Muscarinic Receptor Antagonists for Inhibition of M3-Mediated Phosphoinositide Responses in Guinea Pig Urinary Bladder and Submandibular Salivary Gland
      Carl P. Nelson, Paul Gupta, Carolyn M. Napier, Stefan R. Nahorski and R. A. John Challiss
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1255-1265; DOI: https://doi.org/10.1124/jpet.104.067140
  3. Nally, Rachel E.

    1. You have access
      Ethologically Based Resolution of D2-Like Dopamine Receptor Agonist-versus Antagonist-Induced Behavioral Topography in Dopamine- and Adenosine 3′,5′-Monophosphate-Regulated Phosphoprotein of 32 kDa “Knockout” Mutants Congenic on the C57BL/6 Genetic Background
      Rachel E. Nally, Anthony Kinsella, Orna Tighe, David T. Croke, Allen A. Fienberg, Paul Greengard and John L. Waddington
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1281-1287; DOI: https://doi.org/10.1124/jpet.104.068957
  4. Napier, Carolyn M.

    1. You have access
      Functional Selectivity of Muscarinic Receptor Antagonists for Inhibition of M3-Mediated Phosphoinositide Responses in Guinea Pig Urinary Bladder and Submandibular Salivary Gland
      Carl P. Nelson, Paul Gupta, Carolyn M. Napier, Stefan R. Nahorski and R. A. John Challiss
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1255-1265; DOI: https://doi.org/10.1124/jpet.104.067140
  5. Narahashi, Toshio

    1. You have access
      Mechanism of Action of Galantamine on N-Methyl-d-Aspartate Receptors in Rat Cortical Neurons
      Shigeki Moriguchi, William Marszalec, Xilong Zhao, Jay Z. Yeh and Toshio Narahashi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 933-942; DOI: https://doi.org/10.1124/jpet.104.067603
  6. Navis, Gerjan

    1. You have access
      Low Sodium Modifies the Vascular Effects of Angiotensin-Converting Enzyme Inhibitor Therapy in Healthy Rats
      Menno J. A. Kocks, Simone Gschwend, Dick de Zeeuw, Gerjan Navis and Hendrik Buikema
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1183-1189; DOI: https://doi.org/10.1124/jpet.104.067272
  7. Naydenova, Zlatina

    1. You have access
      The Adenosine Transporter, mENT1, Is a Target for Adenosine Receptor Signaling and Protein Kinase Cϵ in Hypoxic and Pharmacological Preconditioning in the Mouse Cardiomyocyte Cell Line, HL-1
      Naz Chaudary, Zlatina Naydenova, Irina Shuralyova and Imogen R. Coe
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1190-1198; DOI: https://doi.org/10.1124/jpet.104.067157
  8. Nelson, Carl P.

    1. You have access
      Functional Selectivity of Muscarinic Receptor Antagonists for Inhibition of M3-Mediated Phosphoinositide Responses in Guinea Pig Urinary Bladder and Submandibular Salivary Gland
      Carl P. Nelson, Paul Gupta, Carolyn M. Napier, Stefan R. Nahorski and R. A. John Challiss
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1255-1265; DOI: https://doi.org/10.1124/jpet.104.067140
  9. Norrholm, Seth D.

    1. You have access
      Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters
      Dennis K. Miller, Peter A. Crooks, Guangrong Zheng, Vladimir P. Grinevich, Seth D. Norrholm and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1035-1045; DOI: https://doi.org/10.1124/jpet.104.068098
  10. Nunez, Derek J. R.

    1. You have access
      Regional Hemodynamic Effects of the N-(2-Benzoylphenyl)-l-tyrosine Peroxisome Proliferator-Activated Receptor-γ Ligand, GI 262570 [(S)-2-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic Acid], in Conscious Rats
      Sheila M Gardiner, Derek J. R. Nunez, Philip G. Baer, Kathleen K. Brown and Terence Bennett
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1226-1233; DOI: https://doi.org/10.1124/jpet.104.068817

O

  1. Ohizumi, Yasushi

    1. You have access
      IC101 Induces Apoptosis by Akt Dephosphorylation via an Inhibition of Heat Shock Protein 90-ATP Binding Activity Accompanied by Preventing the Interaction with Akt in L1210 Cells
      Hironori Fujiwara, Tohru Yamakuni, Mitsuhiro Ueno, Masaaki Ishizuka, Takashi Shinkawa, Toshiaki Isobe and Yasushi Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1288-1295; DOI: https://doi.org/10.1124/jpet.104.065979
  2. Okada, Shuichi

    1. You have access
      Fenofibrate, Troglitazone, and 15-Deoxy-Δ12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion
      Kenju Shimomura, Hiroyuki Shimizu, Mizuho Ikeda, Shuichi Okada, Masafumi Kakei, Shigeji Matsumoto and Masatomo Mori
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1273-1280; DOI: https://doi.org/10.1124/jpet.104.067249
  3. Olejar, Kenneth J.

    1. You have access
      Inhibition of Bladder Activity by 5-Hydroxytryptamine1 Serotonin Receptor Agonists in Cats with Chronic Spinal Cord Injury
      Baojun Gu, Kenneth J. Olejar, Jerome P. Reiter, Karl B. Thor and Paul C. Dolber
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1266-1272; DOI: https://doi.org/10.1124/jpet.103.063842
  4. Olsen, Richard W.

    1. You have access
      Altered Pharmacology of Synaptic and Extrasynaptic GABAA Receptors on CA1 Hippocampal Neurons Is Consistent with Subunit Changes in a Model of Alcohol Withdrawal and Dependence
      Jing Liang, Elisabetta Cagetti, Richard W. Olsen and Igor Spigelman
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1234-1245; DOI: https://doi.org/10.1124/jpet.104.067983
  5. Ongini, Ennio

    1. You have access
      The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1
      Clara Di Filippo, Francesco Rossi, Ennio Ongini, Piero Del Soldato, Mauro Perretti and Michele D'Amico
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1133-1141; DOI: https://doi.org/10.1124/jpet.104.068726
  6. Orozco, Camilo

    1. You have access
      ITH4012 (Ethyl 5-Amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a Novel Acetylcholinesterase Inhibitor with “Calcium Promotor” and Neuroprotective Properties
      Camilo Orozco, Cristobal de los Rios, Esperanza Arias, Rafael León, Antonio G. García, Jose L. Marco, Mercedes Villarroya and Manuela G. López
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 987-994; DOI: https://doi.org/10.1124/jpet.104.068189
  7. Oustric, Didier

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  8. Oz, Murat

    1. You have access
      Differential Effects of Endogenous and Synthetic Cannabinoids on α7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
      Murat Oz, Li Zhang, Arippa Ravindran, Marisela Morales and Carl R. Lupica
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1152-1160; DOI: https://doi.org/10.1124/jpet.104.067751

P

  1. Padilla-Eagar, J.

    1. You have access
      In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells
      G. P. Coffey, E. Stefanich, S. Palmieri, R. Eckert, J. Padilla-Eagar, P. J. Fielder and S. Pippig
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 896-904; DOI: https://doi.org/10.1124/jpet.104.067611
  2. Palmieri, S.

    1. You have access
      In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells
      G. P. Coffey, E. Stefanich, S. Palmieri, R. Eckert, J. Padilla-Eagar, P. J. Fielder and S. Pippig
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 896-904; DOI: https://doi.org/10.1124/jpet.104.067611
  3. Pandini, M.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  4. Papp, Lilla

    1. You have access
      P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices
      Lilla Papp, Tamás Balázsa, Attila Köfalvi, Ferenc Erdélyi, Gábor Szabó, E. Sylvester Vizi and Beáta Sperlágh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 973-980; DOI: https://doi.org/10.1124/jpet.104.066712
  5. Perego, Carlo

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  6. Pério, Alain

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  7. Perretti, Mauro

    1. You have access
      The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1
      Clara Di Filippo, Francesco Rossi, Ennio Ongini, Piero Del Soldato, Mauro Perretti and Michele D'Amico
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1133-1141; DOI: https://doi.org/10.1124/jpet.104.068726
  8. Perron, C.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  9. Pippig, S.

    1. You have access
      In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells
      G. P. Coffey, E. Stefanich, S. Palmieri, R. Eckert, J. Padilla-Eagar, P. J. Fielder and S. Pippig
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 896-904; DOI: https://doi.org/10.1124/jpet.104.067611
  10. Poncelet, Martine

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  11. Puech, F.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  12. Pyke, Simon M.

    1. You have access
      Strong Protein Adduct Trapping Accompanies Abolition of Acrolein-Mediated Hepatotoxicity by Hydralazine in Mice
      Lisa M. Kaminskas, Simon M. Pyke and Philip C. Burcham
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1003-1010; DOI: https://doi.org/10.1124/jpet.104.067330

R

  1. Rae, James M.

    1. You have access
      Metabolism of N,N′,N″-Triethylenethiophosphoramide by CYP2B1 and CYP2B6 Results in the Inactivation of Both Isoforms by Two Distinct Mechanisms
      Erin Harleton, Marie Webster, Namandjé N. Bumpus, Ute M. Kent, James M. Rae and Paul F. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1011-1019; DOI: https://doi.org/10.1124/jpet.104.069112
  2. Ravindran, Arippa

    1. You have access
      Differential Effects of Endogenous and Synthetic Cannabinoids on α7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
      Murat Oz, Li Zhang, Arippa Ravindran, Marisela Morales and Carl R. Lupica
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1152-1160; DOI: https://doi.org/10.1124/jpet.104.067751
  3. Ray, Prabhati

    1. You have access
      Botulinum Toxin Type A Targets RhoB to Inhibit Lysophosphatidic Acid-Stimulated Actin Reorganization and Acetylcholine Release in Nerve Growth Factor-Treated PC12 Cells
      Hiroshi Ishida, Xieping Zhang, Kelly Erickson and Prabhati Ray
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 881-889; DOI: https://doi.org/10.1124/jpet.104.065318
  4. Reilly, Christopher A.

    1. You have access
      Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung
      Andrea C. Simmonds, Burhan I. Ghanayem, Ashish Sharma, Christopher A. Reilly, Brandie Millen, Garold S. Yost and Poh-Gek Forkert
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 855-864; DOI: https://doi.org/10.1124/jpet.104.068171
  5. Reinhardt, Lindsay E.

    1. You have access
      Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity
      Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676
  6. Reiter, Jerome P.

    1. You have access
      Inhibition of Bladder Activity by 5-Hydroxytryptamine1 Serotonin Receptor Agonists in Cats with Chronic Spinal Cord Injury
      Baojun Gu, Kenneth J. Olejar, Jerome P. Reiter, Karl B. Thor and Paul C. Dolber
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1266-1272; DOI: https://doi.org/10.1124/jpet.103.063842
  7. Reynolds, Jessica L.

    1. You have access
      Brain-Derived Tumor Necrosis Factor-α and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant
      Jessica L. Reynolds, Tracey A. Ignatowski, Reeteka Sud and Robert N. Spengler
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1216-1225; DOI: https://doi.org/10.1124/jpet.104.067835
  8. Richardson, J. Steven

    1. You have access
      Protein Cross-Linkage Induced by Formaldehyde Derived from Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination of Methylamine
      Diana Gubisne-Haberle, Wayne Hill, Mychaylo Kazachkov, J. Steven Richardson and Peter H. Yu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1125-1132; DOI: https://doi.org/10.1124/jpet.104.068601
  9. Rinaldi-Carmona, Murielle

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  10. Rivier, Jean E.

    1. You have access
      Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity
      Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676
  11. Rizzo, Gianni

    1. You have access
      Enhanced Anti-Inflammatory Potency of a Nitric Oxide-Releasing Derivative of Flunisolide: Role of Nuclear Factor-κB
      John L. Wallace, Gianni Rizzo, Giuseppe Cirino, Piero Del Soldato and Stefano Fiorucci
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1096-1102; DOI: https://doi.org/10.1124/jpet.104.067850
  12. Rossi, Francesco

    1. You have access
      The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1
      Clara Di Filippo, Francesco Rossi, Ennio Ongini, Piero Del Soldato, Mauro Perretti and Michele D'Amico
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1133-1141; DOI: https://doi.org/10.1124/jpet.104.068726

S

  1. Scatton, B.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  2. Schlag, Brian D.

    1. You have access
      Ligand Dependency of 5-Hydroxytryptamine 2C Receptor Internalization
      Brian D. Schlag, Zhuangwei Lou, Myles Fennell and John Dunlop
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 865-870; DOI: https://doi.org/10.1124/jpet.104.067306
  3. Scott, Gwen S.

    1. You have access
      The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation
      Gwen S. Scott, Rhonda B. Kean, Tatiana Mikheeva, Marzena J. Fabis, Jon G. Mabley, Csaba Szabó and D. Craig Hooper
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1053-1061; DOI: https://doi.org/10.1124/jpet.103.063214
  4. Segers, Patrick

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  5. Sharma, Ashish

    1. You have access
      Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung
      Andrea C. Simmonds, Burhan I. Ghanayem, Ashish Sharma, Christopher A. Reilly, Brandie Millen, Garold S. Yost and Poh-Gek Forkert
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 855-864; DOI: https://doi.org/10.1124/jpet.104.068171
  6. Shen, Danny D.

    1. You have access
      Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein
      Erica L. Woodahl, Ziping Yang, Tot Bui, Danny D. Shen and Rodney J. Y. Ho
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1199-1207; DOI: https://doi.org/10.1124/jpet.104.065383
  7. Shimizu, Hiroyuki

    1. You have access
      Fenofibrate, Troglitazone, and 15-Deoxy-Δ12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion
      Kenju Shimomura, Hiroyuki Shimizu, Mizuho Ikeda, Shuichi Okada, Masafumi Kakei, Shigeji Matsumoto and Masatomo Mori
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1273-1280; DOI: https://doi.org/10.1124/jpet.104.067249
  8. Shimomura, Kenju

    1. You have access
      Fenofibrate, Troglitazone, and 15-Deoxy-Δ12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion
      Kenju Shimomura, Hiroyuki Shimizu, Mizuho Ikeda, Shuichi Okada, Masafumi Kakei, Shigeji Matsumoto and Masatomo Mori
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1273-1280; DOI: https://doi.org/10.1124/jpet.104.067249
  9. Shinkawa, Takashi

    1. You have access
      IC101 Induces Apoptosis by Akt Dephosphorylation via an Inhibition of Heat Shock Protein 90-ATP Binding Activity Accompanied by Preventing the Interaction with Akt in L1210 Cells
      Hironori Fujiwara, Tohru Yamakuni, Mitsuhiro Ueno, Masaaki Ishizuka, Takashi Shinkawa, Toshiaki Isobe and Yasushi Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1288-1295; DOI: https://doi.org/10.1124/jpet.104.065979
  10. Shuralyova, Irina

    1. You have access
      The Adenosine Transporter, mENT1, Is a Target for Adenosine Receptor Signaling and Protein Kinase Cϵ in Hypoxic and Pharmacological Preconditioning in the Mouse Cardiomyocyte Cell Line, HL-1
      Naz Chaudary, Zlatina Naydenova, Irina Shuralyova and Imogen R. Coe
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1190-1198; DOI: https://doi.org/10.1124/jpet.104.067157
  11. Simmonds, Andrea C.

    1. You have access
      Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung
      Andrea C. Simmonds, Burhan I. Ghanayem, Ashish Sharma, Christopher A. Reilly, Brandie Millen, Garold S. Yost and Poh-Gek Forkert
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 855-864; DOI: https://doi.org/10.1124/jpet.104.068171
  12. Sironi, Luigi

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  13. Sombati, Sompong

    1. You have access
      Epileptogenesis Causes Acute and Chronic Increases in GABAA Receptor Endocytosis That Contributes to the Induction and Maintenance of Seizures in the Hippocampal Culture Model of Acquired Epilepsy
      Robert E. Blair, Sompong Sombati, David C. Lawrence, Brendan D. McCay and Robert J. DeLorenzo
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 871-880; DOI: https://doi.org/10.1124/jpet.104.068478
  14. Son, Thomas

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  15. Sontag, N.

    1. You have access
      SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile
      N. Aubin, P. Barneoud, C. Carter, D. Caille, N. Sontag, C. Marc, J. Lolivier, A. Gardes, C. Perron, A. Le Kim, T. Charieras, M. Pandini, P. Burnier, F. Puech, S. Jegham, P. George, B. Scatton and O. Curet
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1171-1182; DOI: https://doi.org/10.1124/jpet.103.064782
  16. Soubrié, Philippe

    1. You have access
      SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization
      Murielle Rinaldi-Carmona, Francis Barth, Christian Congy, Serge Martinez, Didier Oustric, Alain Pério, Martine Poncelet, Jeanne Maruani, Michèle Arnone, Olivier Finance, Philippe Soubrié and Gérard Le Fur
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 905-914; DOI: https://doi.org/10.1124/jpet.104.067884
  17. Soukhova, Nadia V.

    1. You have access
      Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6
      Zeruesenay Desta, Bryan A. Ward, Nadia V. Soukhova and David A. Flockhart
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1062-1075; DOI: https://doi.org/10.1124/jpet.104.065607
  18. Spalding, Tracy A.

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  19. Spengler, Robert N.

    1. You have access
      Brain-Derived Tumor Necrosis Factor-α and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant
      Jessica L. Reynolds, Tracey A. Ignatowski, Reeteka Sud and Robert N. Spengler
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1216-1225; DOI: https://doi.org/10.1124/jpet.104.067835
  20. Sperlágh, Beáta

    1. You have access
      P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices
      Lilla Papp, Tamás Balázsa, Attila Köfalvi, Ferenc Erdélyi, Gábor Szabó, E. Sylvester Vizi and Beáta Sperlágh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 973-980; DOI: https://doi.org/10.1124/jpet.104.066712
  21. Spigelman, Igor

    1. You have access
      Altered Pharmacology of Synaptic and Extrasynaptic GABAA Receptors on CA1 Hippocampal Neurons Is Consistent with Subunit Changes in a Model of Alcohol Withdrawal and Dependence
      Jing Liang, Elisabetta Cagetti, Richard W. Olsen and Igor Spigelman
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1234-1245; DOI: https://doi.org/10.1124/jpet.104.067983
  22. Spooren, Will P. J. M.

    1. You have access
      Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines
      John F. Cryan, Peter H. Kelly, Frederique Chaperon, Conrad Gentsch, Cedric Mombereau, Kurt Lingenhoehl, Wolfgang Froestl, Bernhard Bettler, Klemens Kaupmann and Will P. J. M. Spooren
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 952-963; DOI: https://doi.org/10.1124/jpet.104.066753
  23. Stefanich, E.

    1. You have access
      In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells
      G. P. Coffey, E. Stefanich, S. Palmieri, R. Eckert, J. Padilla-Eagar, P. J. Fielder and S. Pippig
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 896-904; DOI: https://doi.org/10.1124/jpet.104.067611
  24. Sud, Reeteka

    1. You have access
      Brain-Derived Tumor Necrosis Factor-α and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant
      Jessica L. Reynolds, Tracey A. Ignatowski, Reeteka Sud and Robert N. Spengler
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1216-1225; DOI: https://doi.org/10.1124/jpet.104.067835
  25. Suzuki, Fumiko

    1. You have access
      Identification of α-1L Adrenoceptor in Rabbit Ear Artery
      Yasuko Hiraizumi-Hiraoka, Takashi Tanaka, Hatsumi Yamamoto, Fumiko Suzuki and Ikunobu Muramatsu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 995-1002; DOI: https://doi.org/10.1124/jpet.104.066985
  26. Szabo, Bela

    1. You have access
      Analysis of the Effects of Cannabinoids on Synaptic Transmission between Basket and Purkinje Cells in the Cerebellar Cortex of the Rat
      Bela Szabo, Marta Than, David Thorn and Ilka Wallmichrath
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 915-925; DOI: https://doi.org/10.1124/jpet.104.066670
  27. Szabó, Csaba

    1. You have access
      The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation
      Gwen S. Scott, Rhonda B. Kean, Tatiana Mikheeva, Marzena J. Fabis, Jon G. Mabley, Csaba Szabó and D. Craig Hooper
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1053-1061; DOI: https://doi.org/10.1124/jpet.103.063214
  28. Szabó, Gábor

    1. You have access
      P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices
      Lilla Papp, Tamás Balázsa, Attila Köfalvi, Ferenc Erdélyi, Gábor Szabó, E. Sylvester Vizi and Beáta Sperlágh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 973-980; DOI: https://doi.org/10.1124/jpet.104.066712

T

  1. Tallarida, Ronald J.

    1. You have access
      Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles
      Yury Grabovsky and Ronald J. Tallarida
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 981-986; DOI: https://doi.org/10.1124/jpet.104.067264
  2. Tanaka, Takashi

    1. You have access
      Identification of α-1L Adrenoceptor in Rabbit Ear Artery
      Yasuko Hiraizumi-Hiraoka, Takashi Tanaka, Hatsumi Yamamoto, Fumiko Suzuki and Ikunobu Muramatsu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 995-1002; DOI: https://doi.org/10.1124/jpet.104.066985
  3. Tchana-Sato, Vincent

    1. You have access
      Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism
      Alexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, Philippe Kolh, Vincent Tchana-Sato, Philippe Morimont, David Magis, Julien Hanson, Patrick Segers and Vincent D'Orio
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 964-972; DOI: https://doi.org/10.1124/jpet.104.066852
  4. Than, Marta

    1. You have access
      Analysis of the Effects of Cannabinoids on Synaptic Transmission between Basket and Purkinje Cells in the Cerebellar Cortex of the Rat
      Bela Szabo, Marta Than, David Thorn and Ilka Wallmichrath
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 915-925; DOI: https://doi.org/10.1124/jpet.104.066670
  5. Thor, Karl B.

    1. You have access
      Inhibition of Bladder Activity by 5-Hydroxytryptamine1 Serotonin Receptor Agonists in Cats with Chronic Spinal Cord Injury
      Baojun Gu, Kenneth J. Olejar, Jerome P. Reiter, Karl B. Thor and Paul C. Dolber
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1266-1272; DOI: https://doi.org/10.1124/jpet.103.063842
  6. Thorn, David

    1. You have access
      Analysis of the Effects of Cannabinoids on Synaptic Transmission between Basket and Purkinje Cells in the Cerebellar Cortex of the Rat
      Bela Szabo, Marta Than, David Thorn and Ilka Wallmichrath
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 915-925; DOI: https://doi.org/10.1124/jpet.104.066670
  7. Tighe, Orna

    1. You have access
      Ethologically Based Resolution of D2-Like Dopamine Receptor Agonist-versus Antagonist-Induced Behavioral Topography in Dopamine- and Adenosine 3′,5′-Monophosphate-Regulated Phosphoprotein of 32 kDa “Knockout” Mutants Congenic on the C57BL/6 Genetic Background
      Rachel E. Nally, Anthony Kinsella, Orna Tighe, David T. Croke, Allen A. Fienberg, Paul Greengard and John L. Waddington
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1281-1287; DOI: https://doi.org/10.1124/jpet.104.068957
  8. Tolf, Bo-Ragnar

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  9. Tremoli, Elena

    1. You have access
      Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats
      Cristina Banfi, Luigi Sironi, Grazia De Simoni, Paolo Gelosa, Simona Barcella, Carlo Perego, Elisabetta Gianazza, Uliano Guerrini, Elena Tremoli and Luciana Mussoni
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 890-895; DOI: https://doi.org/10.1124/jpet.104.067090
  10. Tsao, Cheng-Chung

    1. You have access
      CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products
      Tracy C. DeLozier, Cheng-Chung Tsao, Sherry J. Coulter, Julie Foley, J. Alyce Bradbury, Darryl C. Zeldin and Joyce A. Goldstein
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 845-854; DOI: https://doi.org/10.1124/jpet.104.067819

U

  1. Ueno, Mitsuhiro

    1. You have access
      IC101 Induces Apoptosis by Akt Dephosphorylation via an Inhibition of Heat Shock Protein 90-ATP Binding Activity Accompanied by Preventing the Interaction with Akt in L1210 Cells
      Hironori Fujiwara, Tohru Yamakuni, Mitsuhiro Ueno, Masaaki Ishizuka, Takashi Shinkawa, Toshiaki Isobe and Yasushi Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1288-1295; DOI: https://doi.org/10.1124/jpet.104.065979

V

  1. Valdez, Glenn R.

    1. You have access
      Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity
      Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676
  2. Vale, Wylie W.

    1. You have access
      Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity
      Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676
  3. Vanover, Kimberly E.

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  4. Veinbergs, Isaac

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  5. Villarroya, Mercedes

    1. You have access
      ITH4012 (Ethyl 5-Amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a Novel Acetylcholinesterase Inhibitor with “Calcium Promotor” and Neuroprotective Properties
      Camilo Orozco, Cristobal de los Rios, Esperanza Arias, Rafael León, Antonio G. García, Jose L. Marco, Mercedes Villarroya and Manuela G. López
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 987-994; DOI: https://doi.org/10.1124/jpet.104.068189
  6. Vizi, E. Sylvester

    1. You have access
      P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices
      Lilla Papp, Tamás Balázsa, Attila Köfalvi, Ferenc Erdélyi, Gábor Szabó, E. Sylvester Vizi and Beáta Sperlágh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 973-980; DOI: https://doi.org/10.1124/jpet.104.066712

W

  1. Waddington, John L.

    1. You have access
      Ethologically Based Resolution of D2-Like Dopamine Receptor Agonist-versus Antagonist-Induced Behavioral Topography in Dopamine- and Adenosine 3′,5′-Monophosphate-Regulated Phosphoprotein of 32 kDa “Knockout” Mutants Congenic on the C57BL/6 Genetic Background
      Rachel E. Nally, Anthony Kinsella, Orna Tighe, David T. Croke, Allen A. Fienberg, Paul Greengard and John L. Waddington
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1281-1287; DOI: https://doi.org/10.1124/jpet.104.068957
  2. Wallace, John L.

    1. You have access
      Enhanced Anti-Inflammatory Potency of a Nitric Oxide-Releasing Derivative of Flunisolide: Role of Nuclear Factor-κB
      John L. Wallace, Gianni Rizzo, Giuseppe Cirino, Piero Del Soldato and Stefano Fiorucci
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1096-1102; DOI: https://doi.org/10.1124/jpet.104.067850
  3. Wallmichrath, Ilka

    1. You have access
      Analysis of the Effects of Cannabinoids on Synaptic Transmission between Basket and Purkinje Cells in the Cerebellar Cortex of the Rat
      Bela Szabo, Marta Than, David Thorn and Ilka Wallmichrath
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 915-925; DOI: https://doi.org/10.1124/jpet.104.066670
  4. Ward, Bryan A.

    1. You have access
      Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6
      Zeruesenay Desta, Bryan A. Ward, Nadia V. Soukhova and David A. Flockhart
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1062-1075; DOI: https://doi.org/10.1124/jpet.104.065607
  5. Webster, Marie

    1. You have access
      Metabolism of N,N′,N″-Triethylenethiophosphoramide by CYP2B1 and CYP2B6 Results in the Inactivation of Both Isoforms by Two Distinct Mechanisms
      Erin Harleton, Marie Webster, Namandjé N. Bumpus, Ute M. Kent, James M. Rae and Paul F. Hollenberg
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1011-1019; DOI: https://doi.org/10.1124/jpet.104.069112
  6. Weiner, David M.

    1. You have access
      Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
      Kimberly E. Vanover, Scott C. Harvey, Thomas Son, Stefania Risso Bradley, Henriette Kold, Malath Makhay, Isaac Veinbergs, Tracy A. Spalding, David M. Weiner, Carl Magnus Andersson, Bo-Ragnar Tolf, Mark R. Brann, Uli Hacksell and Robert E. Davis
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 943-951; DOI: https://doi.org/10.1124/jpet.104.066688
  7. Wilhelm, Clare J.

    1. You have access
      Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System
      Clare J. Wilhelm, Robert A. Johnson, Paul G. Lysko, Amy J. Eshleman and Aaron Janowsky
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1142-1151; DOI: https://doi.org/10.1124/jpet.104.067314
  8. Williams, D. Clive

    1. You have access
      Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XL
      Margaret M. Mc Gee, Lisa M. Greene, Susan Ledwidge, Giuseppe Campiani, Vito Nacci, Mark Lawler, D. Clive Williams and Daniela M. Zisterer
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1084-1095; DOI: https://doi.org/10.1124/jpet.104.067561
  9. Woodahl, Erica L.

    1. You have access
      Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein
      Erica L. Woodahl, Ziping Yang, Tot Bui, Danny D. Shen and Rodney J. Y. Ho
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1199-1207; DOI: https://doi.org/10.1124/jpet.104.065383

X

  1. Xia, Ning

    1. You have access
      Flavonoids from Artichoke (Cynara scolymus L.) Up-Regulate Endothelial-Type Nitric-Oxide Synthase Gene Expression in Human Endothelial Cells
      Huige Li, Ning Xia, Isolde Brausch, Ying Yao and Ulrich Förstermann
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 926-932; DOI: https://doi.org/10.1124/jpet.104.066639

Y

  1. Yamakuni, Tohru

    1. You have access
      IC101 Induces Apoptosis by Akt Dephosphorylation via an Inhibition of Heat Shock Protein 90-ATP Binding Activity Accompanied by Preventing the Interaction with Akt in L1210 Cells
      Hironori Fujiwara, Tohru Yamakuni, Mitsuhiro Ueno, Masaaki Ishizuka, Takashi Shinkawa, Toshiaki Isobe and Yasushi Ohizumi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1288-1295; DOI: https://doi.org/10.1124/jpet.104.065979
  2. Yamamoto, Hatsumi

    1. You have access
      Identification of α-1L Adrenoceptor in Rabbit Ear Artery
      Yasuko Hiraizumi-Hiraoka, Takashi Tanaka, Hatsumi Yamamoto, Fumiko Suzuki and Ikunobu Muramatsu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 995-1002; DOI: https://doi.org/10.1124/jpet.104.066985
  3. Yamamoto, Hirofumi

    1. You have access
      A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
      Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki, Shigeru Matsuura, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1114-1124; DOI: https://doi.org/10.1124/jpet.104.068932
  4. Yamazaki, Syunji

    1. You have access
      A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
      Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki, Shigeru Matsuura, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1114-1124; DOI: https://doi.org/10.1124/jpet.104.068932
  5. Yang, Ziping

    1. You have access
      Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein
      Erica L. Woodahl, Ziping Yang, Tot Bui, Danny D. Shen and Rodney J. Y. Ho
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1199-1207; DOI: https://doi.org/10.1124/jpet.104.065383
  6. Yao, Ying

    1. You have access
      Flavonoids from Artichoke (Cynara scolymus L.) Up-Regulate Endothelial-Type Nitric-Oxide Synthase Gene Expression in Human Endothelial Cells
      Huige Li, Ning Xia, Isolde Brausch, Ying Yao and Ulrich Förstermann
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 926-932; DOI: https://doi.org/10.1124/jpet.104.066639
  7. Yeh, Jay Z.

    1. You have access
      Mechanism of Action of Galantamine on N-Methyl-d-Aspartate Receptors in Rat Cortical Neurons
      Shigeki Moriguchi, William Marszalec, Xilong Zhao, Jay Z. Yeh and Toshio Narahashi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 933-942; DOI: https://doi.org/10.1124/jpet.104.067603
  8. Yost, Garold S.

    1. You have access
      Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung
      Andrea C. Simmonds, Burhan I. Ghanayem, Ashish Sharma, Christopher A. Reilly, Brandie Millen, Garold S. Yost and Poh-Gek Forkert
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 855-864; DOI: https://doi.org/10.1124/jpet.104.068171
  9. Yu, Peter H.

    1. You have access
      Protein Cross-Linkage Induced by Formaldehyde Derived from Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination of Methylamine
      Diana Gubisne-Haberle, Wayne Hill, Mychaylo Kazachkov, J. Steven Richardson and Peter H. Yu
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1125-1132; DOI: https://doi.org/10.1124/jpet.104.068601

Z

  1. Zeldin, Darryl C.

    1. You have access
      CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products
      Tracy C. DeLozier, Cheng-Chung Tsao, Sherry J. Coulter, Julie Foley, J. Alyce Bradbury, Darryl C. Zeldin and Joyce A. Goldstein
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 845-854; DOI: https://doi.org/10.1124/jpet.104.067819
  2. Zhang, Li

    1. You have access
      Differential Effects of Endogenous and Synthetic Cannabinoids on α7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
      Murat Oz, Li Zhang, Arippa Ravindran, Marisela Morales and Carl R. Lupica
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1152-1160; DOI: https://doi.org/10.1124/jpet.104.067751
  3. Zhang, Xieping

    1. You have access
      Botulinum Toxin Type A Targets RhoB to Inhibit Lysophosphatidic Acid-Stimulated Actin Reorganization and Acetylcholine Release in Nerve Growth Factor-Treated PC12 Cells
      Hiroshi Ishida, Xieping Zhang, Kelly Erickson and Prabhati Ray
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 881-889; DOI: https://doi.org/10.1124/jpet.104.065318
  4. Zhao, Xilong

    1. You have access
      Mechanism of Action of Galantamine on N-Methyl-d-Aspartate Receptors in Rat Cortical Neurons
      Shigeki Moriguchi, William Marszalec, Xilong Zhao, Jay Z. Yeh and Toshio Narahashi
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 933-942; DOI: https://doi.org/10.1124/jpet.104.067603
  5. Zheng, Guangrong

    1. You have access
      Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters
      Dennis K. Miller, Peter A. Crooks, Guangrong Zheng, Vladimir P. Grinevich, Seth D. Norrholm and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1035-1045; DOI: https://doi.org/10.1124/jpet.104.068098
  6. Zisterer, Daniela M.

    1. You have access
      Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XL
      Margaret M. Mc Gee, Lisa M. Greene, Susan Ledwidge, Giuseppe Campiani, Vito Nacci, Mark Lawler, D. Clive Williams and Daniela M. Zisterer
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1084-1095; DOI: https://doi.org/10.1124/jpet.104.067561
  7. Zorrilla, Eric P.

    1. You have access
      Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity
      Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1027-1034; DOI: https://doi.org/10.1124/jpet.104.068676
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 310 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 310, Issue 3
1 Sep 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics